BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1162947)

  • 21. The status of measles after five years of mass vaccination in the USSR.
    Burgasov PN; Andzaparidze OG; Popov VF
    Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The national vaccination program against measles].
    Cohen H; Brouwer R; Bijkerk H; Phaff JM
    Ned Tijdschr Geneeskd; 1978 Jan; 122(2):46-51. PubMed ID: 619292
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans.
    Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D
    Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles IgM response during reinfection of previously vaccinated children.
    Linnemann CC; Hegg ME; Rotte TC; Phair JP; Schiff GM
    J Pediatr; 1973 May; 82(5):798-801. PubMed ID: 4698953
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the combined use of killed and live measles vaccines. I. Correlation between antibody titers following injection of killed vaccine and clinical reactions after live vaccine inoculation.
    Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
    Biken J; 1965 Jun; 8(2):73-9. PubMed ID: 5837766
    [No Abstract]   [Full Text] [Related]  

  • 26. Optimal age for measles vaccination.
    Vidyashankar C
    J Indian Med Assoc; 2002 Jan; 100(1):24-6. PubMed ID: 12206338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles vaccine in the People's Republic of China.
    Xiang JZ; Chen ZH
    Rev Infect Dis; 1983; 5(3):506-10. PubMed ID: 6879006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epidemiological investigations on measles in unvaccinated and vaccinated children (author's transl)].
    Wiedermann G; Ambrosch F
    Wien Klin Wochenschr; 1976 Sep; 88(17):545-54. PubMed ID: 997537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SUPPRESSION OF MEASLES 19S ANTIBODY FORMATION AS EVIDENCE OF IMMUNITY. PRIMARY IMMUNE RESPONSE MASKED BY MATERIAL ANTIBODY.
    SCHLUEDERBERG A; KARELITZ S
    JAMA; 1965 Mar; 191():1064-6. PubMed ID: 14267895
    [No Abstract]   [Full Text] [Related]  

  • 30. WHO-supported comparative studies of attenuated live measles virus vaccines.
    Cockburn WC; Pecenka J; Sundaresan T
    Bull World Health Organ; 1966; 34(2):223-31. PubMed ID: 4161187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
    Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
    Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunoglobulins level in saliva of children with poliomyelitis and of healthy children after oral vaccination with live attenuated poliovirus strains type 2 and 3.
    Szczepski O; Wlodarczak K; Walczak M; Walter Z; Klauziński R
    Pol Med J; 1970; 9(5):1168-72. PubMed ID: 4101723
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunological reactivity of children vaccinated with a live measles vaccine].
    Bolotovskiĭ VM; Titova NS; Zakharova TR; Vorotyntseva NV; Mushkova EM
    Vopr Virusol; 1983; 28(5):588-90. PubMed ID: 6659474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Postvaccinal antimeasles immunity in children with allergic diseases].
    Kostinov MP; Sadykova DK; Balabolkin II; Ignat'eva GV; Gervazieva VB; Gerasimova AG; Agapushkina GG
    Vopr Virusol; 1990; 35(6):512-3. PubMed ID: 2082559
    [No Abstract]   [Full Text] [Related]  

  • 35. Measles vaccination. V. The booster effect of purified hemagglutinin in children previously immunized with this product or formalin-killed vaccine.
    Norrby E; Lagercrantz R; Gard S
    Acta Paediatr Scand; 1966 Jan; 55(1):73-8. PubMed ID: 5919475
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative analysis of the degree of specific humoral immunity, content of serum immunoglobulins and isolation of vaccinia virus in children with post-vaccinal encephalitis after smallpox vaccination.
    Gurvich EB
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(3):311-20. PubMed ID: 6117594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.
    Dai B; Chen ZH; Liu QC; Wu T; Guo CY; Wang XZ; Fang HH; Xiang YZ
    Bull World Health Organ; 1991; 69(4):415-23. PubMed ID: 1934235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transferrin, immunoglobulins and prognosis in measles in the tropics.
    Geddes TD; Gregory WJ
    Trop Geogr Med; 1974 Mar; 26(1):79-83. PubMed ID: 4830623
    [No Abstract]   [Full Text] [Related]  

  • 39. Anthropometric status, serum prealbumin level and immune response to measles vaccination in Mali children.
    Dao H; Delisle H; Fournier P
    J Trop Pediatr; 1992 Aug; 38(4):179-84. PubMed ID: 1527814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Humoral immunity in atopic dermatitis. II. Serum immunoglobulins A, G and M in the blood of patients with atopic dermatitis].
    Przyk K; Ruszczak Z; Czarnecki M
    Przegl Dermatol; 1980; 67(6):729-33. PubMed ID: 7244251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.